Opioid-Free Pain Control Regiment Following Robotic Radical Prostatectomy

• Status: Not yet recruiting
• Trial end date: 2022-01-01
• Target enrollment: 0
• Participant gender: Male

Summary

This study will address the gaps in research of non-opioid postoperative pain management for prostatectomies.

• Phase: Phase 2/Phase 3
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Wake Forest University Health Sciences
• Treatments: Acetaminophen; Acetaminophen, hydrocodone drug combination; Analgesics, Opioid; Gabapentin; Hydrocodone; Ketamine; Ketorolac; Ketorolac Tromethamine; Oxycodone; Tramadol

Criteria

Inclusion Criteria:

• All men ages 40-75 undergoing bilateral robot assisted radical prostatectomy (RARP) with bilateral lymph node dissection with low-intermediate to high-risk localized prostate cancer

Exclusion Criteria:

• Allergies to any medication involved in the study

• T4 prostate cancer

• incarcerated persons

• chronic narcotic dependence

• any current prescription for narcotics

• any surgery in the past 6 months